Screener
Collegium Pharmaceutical, Inc. COLL Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $150.38M+8.8% | $289.56M+147% | $252.16M+161% | $150.1M+285% | $138.25M-20.0% | ||
| —— | $157.34M+54.9% | $0-100% | $135.77M+67.6% | $104.81M+6.1% | ||
| $285.1M+33.8% | $228.76M0.0% | $211.33M-7.5% | $233.95M+2.4% | $213.02M+15.9% | ||
| $8.05M-78.9% | $9.71M-73.9% | $14.01M-60.6% | $38.05M+0.1% | $38.15M+36.9% | ||
| $608.01M+10.7% | $745.67M+41.3% | $691.41M+43.4% | $613.87M+38.3% | $549.21M+7.6% | ||
| $10.65M-17.4% | $11.66M-15.8% | $12.01M-16.2% | $12.25M-16.2% | $12.9M-13.8% | ||
| $190.18M+28.6% | $145.93M-3.2% | $145.93M-10.1% | $145.93M0.0% | $147.94M+10.5% | ||
| $1.19B+52.0% | $614.04M-26.5% | $669.51M-24.9% | $724.98M-23.4% | $780.46M+121% | ||
| $2.14B+34.1% | $1.65B+1.3% | $1.66B-0.4% | $1.61B-1.7% | $1.59B+51.2% | ||
| $9.24M-15.1% | $6.83M-61.8% | $10.66M+171% | $7.65M+143% | $10.89M+351% | ||
| $667K— | $667K— | $667K— | $667K— | —— | ||
| $589.86M+27.0% | $434.97M-10.6% | $440.03M-13.6% | $452.93M-1.4% | $464.61M+0.6% | ||
| $38.53M-97.2% | $1.34B-4.1% | $1.36B-5.5% | $1.33B-4.9% | $1.36B+62.6% | ||
| 100M+249,900% | 100M+249,900% | 100M+249,900% | 41K+2.5% | 40K0.0% | ||
| -$101.68M+32.0% | -$86.63M+46.4% | -$101.13M+38.3% | -$118.09M+33.1% | -$149.6M+19.5% | ||
| $311.91M+34.3% | $312.42M+33.3% | $301.68M+31.8% | $274.81M+17.3% | $232.21M+7.2% | ||
| $2.14B+34.1% | $1.65B+1.3% | $1.66B-0.4% | $1.61B-1.7% | $1.59B+51.2% |
FAQ
- What are Collegium Pharmaceutical, Inc.'s total assets?
- Collegium Pharmaceutical, Inc. (COLL) holds $2.1B in total assets, up 34.1% year over year.
- How much debt does Collegium Pharmaceutical, Inc. have?
- Collegium Pharmaceutical, Inc. carries $5.0M in total debt against $311.9M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Collegium Pharmaceutical, Inc. have?
- Collegium Pharmaceutical, Inc. holds $150.4M in cash and equivalents.
- Can Collegium Pharmaceutical, Inc. cover its short-term obligations?
- Its current ratio is 1.03 — current assets exceed current liabilities.
- Where does Collegium Pharmaceutical, Inc.'s balance sheet data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
